Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001714.4(BICD1):c.1704G>C(p.Val568Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 1,613,888 control chromosomes in the GnomAD database, including 45,181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
BICD1 (HGNC:1049): (BICD cargo adaptor 1) This gene encodes an adaptor protein that belongs to the bicaudal D family of dynein cargo adaptors. The encoded protein acts as an intracellular cargo transport cofactor that regulates the microtubule-based loading of cargo onto the dynein motor complex. It also controls dynein motor activity and coordination. It has a domain architecture consisting of coiled-coil domains at the N- and C-termini that are highly conserved in other family members. Naturally occurring mutations in this gene are associated with short telomere length and emphysema. [provided by RefSeq, Aug 2017]
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 12-32328159-G-C is Benign according to our data. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32328159-G-C is described in CliVar as Benign. Clinvar id is 402425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.847 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.58 is higher than 0.05.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -